UnknownNot applicableNCT05245045
Efficacy and Safety of STBF Photodynamic Therapy for Moderate and Severe Acne Vulgaris
Studying Anterior cutaneous nerve entrapment syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Shanghai Dermatology Hospital
- Principal Investigator
- Xiuli Wang, MDShanghai Skin Disease Hospital
- Intervention
- Shengtaibufen Photodynamic Therapy(STBF-PDT)(procedure)
- Enrollment
- 20 target
- Eligibility
- 18-40 years · All sexes
- Timeline
- 2022 – 2023
Study locations (1)
- Hospital, Shanghai, Shanghai Municipality, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05245045 on ClinicalTrials.govOther trials for Anterior cutaneous nerve entrapment syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE4NCT07544251Comparing Sarecycline and Doxycycline Effects on the Skin and Gut Bacteria in Acne.Integrative Skin Science and Research
- RECRUITINGNANCT07406893Reduction of Bacterial Seeding in Total Shoulder ArthroplastySt. Louis University
- RECRUITINGPHASE2NCT07366229Topical Application of Engineered Lactobacillus Reuteri With a Zinc Sulfate-Tannic Acid MPN Coating for AcneShenzhen People's Hospital
- ACTIVE NOT RECRUITINGNCT07205107Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Triple Combination Gel in Canadian Patients With Acne VulgarisBausch Health Americas, Inc.
- RECRUITINGNANCT07056673Cold Atmospheric Plasma for Moderate-to-severe Acne Vulgaris StudyShenyang Medical College
- RECRUITINGPHASE3NCT06447480Clinical Trial to Compare Oral Isotretinoin to Standard of Care in Moderate Acne Skin of Color PatientsCentre Hospitalier Universitaire de Nice
- RECRUITINGNCT06850389PMCF Investigation of Medical Device ChitoCare® MedicalPrimex ehf
- RECRUITINGPHASE1NCT06989840Phase 1 Study to Evaluate the Safety, Tolerability, PK, and PD of TVB-3567 in Healthy Participants With or Without AcneSagimet Biosciences Inc.
See all trials for Anterior cutaneous nerve entrapment syndrome →